Gianna Melillo

Researchers outline factors that may inhibit immune checkpoint inhibitor efficacy in patients with melanoma.

The FDA has approved empagliflozin (Jardiance) for adults with heart failure with reduced ejection fraction, regardless of type 2 diabetes status.

Study results point to a potential link between immunoglobin G (IgG) antibodies and migraine frequency, severity, and comorbidities.

JDRF, the world's largest nonprofit funder of type 1 diabetes research, announced the appointment of Shereef Elnahal, MD, to its research committee.

Top US health officials outlined plans for rolling out COVID-19 booster shots to all American adults beginning in September, while CMS announced that nursing homes will be required to implement mandatory vaccinations for staff.

An analysis of gestational diabetes trends in the United States revealed increases across all age and racial subgroups over the past decade.

Mary Pat Gallagher, MD, of NYU Langone Health, outlines why young individuals should be vaccinated against COVID-19 and Finnish data on increased rates of type 1 diabetes (T1D) seen during the pandemic.

Researchers evaluated differences among patients with migraine who were diagnosed with the condition upon hospital admission.

Catlin Dennis, MPH, explains the importance of securing internet and technology access among vulnerable youth with diabetes.

Findings of a randomized controlled trial revealed no differences among HIV diagnosis rates between targeted screening practices when compared with nontargeted practices.

Survey results underscore parents’ frustration with insurers when it comes to caring for their children with rare diseases.

Researchers compared billing codes from electronic health records to accurately quantify how many skin cancers patients had.

Investigators conducted a questionnaire-based study among patients who suffered pediatric migraine or tension-type headache.

In a recently published review, authors assessed the relationship between poor bone health and type 1 diabetes (T1D) and outlined potential mechanisms that may account for the association.

Bobeck Modjtahedi, MD, elaborates on the importance of devising effective and convenient mechanisms for diabetic retinopathy screening.

New research published in JAMA Network Open highlights one potential cause of migraine.

Camillo Ricordi, MD, FNAI, outlines the current status of islet transplantation for patients with type 1 diabetes in the United States.

Study results indicate abnormalities in the vestibular cortical network may help researchers understand the underlying mechanisms of vestibular migraine.

The combined toll of the COVID-19 pandemic and the health effects of climate change tests an already beleaguered US health system.

Results of an observational study suggest retinal nerve fiber layer atrophy and the presence of oligoclonal bands may serve as biomarkers for cognitive decline in patients with multiple sclerosis (MS).

Results of a cross-sectional study point to a potential link between iron intake and migraine that may be dependent on age.

David McIntyre, MD, FRACP, outlines how metabolic factors could impact the severity of COVID-19 infections among pregnant people.

Leslie Eiland, MD, outlines some of the challenges of delivering optimal care to patients with type 1 diabetes (T1D) living in rural America.

New research shows central obesity is associated with an increased risk of poor heart failure outcomes among those with type 1 diabetes.

Here are some of the latest developments in multiple sclerosis (MS) from our sister publication, NeurologyLive®.

A newly released internal CDC report shows the agency's communication struggles and its challenges in combatting the virulent delta variant, acknowledges the need for universal masking, and illustrates the effectiveness of vaccines in preventing more severe illness and death in those who are inoculated.

Review findings outline the gut microbiome's potential impact on immunotherapy responses.

New research indicates an association between longer chronic kidney disease duration and taste dysfunction.

Results of post hoc analyses highlight erenumab's efficacy in reducing headache medication use among migraineurs.

Aleksandar Kostic, PhD, an assistant professor of microbiology at Harvard Medical School, explains how a microbially targeted vaccine may prevent type 1 diabetes (T1D).